Selected research
Industry Research
Large-Scale Oligonucleotide Synthesis Services Industry Research Report 2026
Market perspective
The global Large-Scale Oligonucleotide Synthesis Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Large-Scale Oligonucleotide Synthesis Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Large-Scale Oligonucleotide Synthesis Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Large-Scale Oligonucleotide Synthesis Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Large-Scale Oligonucleotide Synthesis Services include Thermo Fisher Scientific, Merck, Genscript, Guangzhou RiboBio, Tsingke, Abace Biotechnology, TriLink BioTechnologies, Synbio Technologies and Macrogen, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Large-Scale Oligonucleotide Synthesis Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Large-Scale Oligonucleotide Synthesis Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Large-Scale Oligonucleotide Synthesis Services Market by Company
Thermo Fisher Scientific
Merck
Genscript
Guangzhou RiboBio
Tsingke
Abace Biotechnology
TriLink BioTechnologies
Synbio Technologies
Macrogen
Integrated DNA Technologies (IDT)
Eurogentec
Cusabio
BBI Life Sciences
Azenta Life Sciences
Aurigene Pharmaceutical Services
Large-Scale Oligonucleotide Synthesis Services Segment by Type
Common Primer Synthesis
Modified Primer Synthesis
Large-Scale Oligonucleotide Synthesis Services Segment by Application
Biotech Company
Academic Scientific Research Institution
Large-Scale Oligonucleotide Synthesis Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Large-Scale Oligonucleotide Synthesis Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Large-Scale Oligonucleotide Synthesis Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Large-Scale Oligonucleotide Synthesis Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Large-Scale Oligonucleotide Synthesis Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Common Primer Synthesis
- Modified Primer Synthesis
Applications
- Biotech Company
- Academic Scientific Research Institution
Companies covered
- Thermo Fisher Scientific
- Merck
- Genscript
- Guangzhou RiboBio
- Tsingke
- Abace Biotechnology
- TriLink BioTechnologies
- Synbio Technologies
- Macrogen
- Integrated DNA Technologies (IDT)
- Eurogentec
- Cusabio
- BBI Life Sciences
- Azenta Life Sciences
- Aurigene Pharmaceutical Services
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Large-Scale Oligonucleotide Synthesis Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Common Primer Synthesis
- 2.2.3 Modified Primer Synthesis
- 2.3 Large-Scale Oligonucleotide Synthesis Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biotech Company
- 2.3.3 Academic Scientific Research Institution
- 2.4 Assumptions and Limitations
3 Large-Scale Oligonucleotide Synthesis Services Breakdown Data by Type
- 3.1 Global Large-Scale Oligonucleotide Synthesis Services Historic Market Size by Type (2021-2026)
- 3.2 Global Large-Scale Oligonucleotide Synthesis Services Forecasted Market Size by Type (2027-2032)
4 Large-Scale Oligonucleotide Synthesis Services Breakdown Data by Application
- 4.1 Global Large-Scale Oligonucleotide Synthesis Services Historic Market Size by Application (2021-2026)
- 4.2 Global Large-Scale Oligonucleotide Synthesis Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Large-Scale Oligonucleotide Synthesis Services Market Perspective (2021-2032)
- 5.2 Global Large-Scale Oligonucleotide Synthesis Services Growth Trends by Region
- 5.2.1 Global Large-Scale Oligonucleotide Synthesis Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Large-Scale Oligonucleotide Synthesis Services Historic Market Size by Region (2021-2026)
- 5.2.3 Large-Scale Oligonucleotide Synthesis Services Forecasted Market Size by Region (2027-2032)
- 5.3 Large-Scale Oligonucleotide Synthesis Services Market Dynamics
- 5.3.1 Large-Scale Oligonucleotide Synthesis Services Industry Trends
- 5.3.2 Large-Scale Oligonucleotide Synthesis Services Market Drivers
- 5.3.3 Large-Scale Oligonucleotide Synthesis Services Market Challenges
- 5.3.4 Large-Scale Oligonucleotide Synthesis Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Large-Scale Oligonucleotide Synthesis Services Players by Revenue
- 6.1.1 Global Top Large-Scale Oligonucleotide Synthesis Services Players by Revenue (2021-2026)
- 6.1.2 Global Large-Scale Oligonucleotide Synthesis Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Large-Scale Oligonucleotide Synthesis Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Large-Scale Oligonucleotide Synthesis Services Head Office and Area Served
- 6.4 Global Large-Scale Oligonucleotide Synthesis Services Players, Product Type & Application
- 6.5 Global Large-Scale Oligonucleotide Synthesis Services Manufacturers Established Date
- 6.6 Global Large-Scale Oligonucleotide Synthesis Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Large-Scale Oligonucleotide Synthesis Services Market Size (2021-2032)
- 7.2 North America Large-Scale Oligonucleotide Synthesis Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Large-Scale Oligonucleotide Synthesis Services Market Size by Country (2021-2026)
- 7.4 North America Large-Scale Oligonucleotide Synthesis Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Large-Scale Oligonucleotide Synthesis Services Market Size (2021-2032)
- 8.2 Europe Large-Scale Oligonucleotide Synthesis Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Large-Scale Oligonucleotide Synthesis Services Market Size by Country (2021-2026)
- 8.4 Europe Large-Scale Oligonucleotide Synthesis Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Large-Scale Oligonucleotide Synthesis Services Market Size (2021-2032)
- 9.2 Asia-Pacific Large-Scale Oligonucleotide Synthesis Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Large-Scale Oligonucleotide Synthesis Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Large-Scale Oligonucleotide Synthesis Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Large-Scale Oligonucleotide Synthesis Services Market Size (2021-2032)
- 10.2 South America Large-Scale Oligonucleotide Synthesis Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Large-Scale Oligonucleotide Synthesis Services Market Size by Country (2021-2026)
- 10.4 South America Large-Scale Oligonucleotide Synthesis Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Large-Scale Oligonucleotide Synthesis Services Market Size (2021-2032)
- 11.2 Middle East & Africa Large-Scale Oligonucleotide Synthesis Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Large-Scale Oligonucleotide Synthesis Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Large-Scale Oligonucleotide Synthesis Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific
- 12.1.1 Thermo Fisher Scientific Company Information
- 12.1.2 Thermo Fisher Scientific Business Overview
- 12.1.3 Thermo Fisher Scientific Revenue in Large-Scale Oligonucleotide Synthesis Services Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 12.1.5 Thermo Fisher Scientific Recent Developments
- 12.2 Merck
- 12.2.1 Merck Company Information
- 12.2.2 Merck Business Overview
- 12.2.3 Merck Revenue in Large-Scale Oligonucleotide Synthesis Services Business (2021-2026)
- 12.2.4 Merck Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 12.2.5 Merck Recent Developments
- 12.3 Genscript
- 12.3.1 Genscript Company Information
- 12.3.2 Genscript Business Overview
- 12.3.3 Genscript Revenue in Large-Scale Oligonucleotide Synthesis Services Business (2021-2026)
- 12.3.4 Genscript Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 12.3.5 Genscript Recent Developments
- 12.4 Guangzhou RiboBio
- 12.4.1 Guangzhou RiboBio Company Information
- 12.4.2 Guangzhou RiboBio Business Overview
- 12.4.3 Guangzhou RiboBio Revenue in Large-Scale Oligonucleotide Synthesis Services Business (2021-2026)
- 12.4.4 Guangzhou RiboBio Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 12.4.5 Guangzhou RiboBio Recent Developments
- 12.5 Tsingke
- 12.5.1 Tsingke Company Information
- 12.5.2 Tsingke Business Overview
- 12.5.3 Tsingke Revenue in Large-Scale Oligonucleotide Synthesis Services Business (2021-2026)
- 12.5.4 Tsingke Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 12.5.5 Tsingke Recent Developments
- 12.6 Abace Biotechnology
- 12.6.1 Abace Biotechnology Company Information
- 12.6.2 Abace Biotechnology Business Overview
- 12.6.3 Abace Biotechnology Revenue in Large-Scale Oligonucleotide Synthesis Services Business (2021-2026)
- 12.6.4 Abace Biotechnology Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 12.6.5 Abace Biotechnology Recent Developments
- 12.7 TriLink BioTechnologies
- 12.7.1 TriLink BioTechnologies Company Information
- 12.7.2 TriLink BioTechnologies Business Overview
- 12.7.3 TriLink BioTechnologies Revenue in Large-Scale Oligonucleotide Synthesis Services Business (2021-2026)
- 12.7.4 TriLink BioTechnologies Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 12.7.5 TriLink BioTechnologies Recent Developments
- 12.8 Synbio Technologies
- 12.8.1 Synbio Technologies Company Information
- 12.8.2 Synbio Technologies Business Overview
- 12.8.3 Synbio Technologies Revenue in Large-Scale Oligonucleotide Synthesis Services Business (2021-2026)
- 12.8.4 Synbio Technologies Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 12.8.5 Synbio Technologies Recent Developments
- 12.9 Macrogen
- 12.9.1 Macrogen Company Information
- 12.9.2 Macrogen Business Overview
- 12.9.3 Macrogen Revenue in Large-Scale Oligonucleotide Synthesis Services Business (2021-2026)
- 12.9.4 Macrogen Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 12.9.5 Macrogen Recent Developments
- 12.10 Integrated DNA Technologies (IDT)
- 12.10.1 Integrated DNA Technologies (IDT) Company Information
- 12.10.2 Integrated DNA Technologies (IDT) Business Overview
- 12.10.3 Integrated DNA Technologies (IDT) Revenue in Large-Scale Oligonucleotide Synthesis Services Business (2021-2026)
- 12.10.4 Integrated DNA Technologies (IDT) Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 12.10.5 Integrated DNA Technologies (IDT) Recent Developments
- 12.11 Eurogentec
- 12.11.1 Eurogentec Company Information
- 12.11.2 Eurogentec Business Overview
- 12.11.3 Eurogentec Revenue in Large-Scale Oligonucleotide Synthesis Services Business (2021-2026)
- 12.11.4 Eurogentec Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 12.11.5 Eurogentec Recent Developments
- 12.12 Cusabio
- 12.12.1 Cusabio Company Information
- 12.12.2 Cusabio Business Overview
- 12.12.3 Cusabio Revenue in Large-Scale Oligonucleotide Synthesis Services Business (2021-2026)
- 12.12.4 Cusabio Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 12.12.5 Cusabio Recent Developments
- 12.13 BBI Life Sciences
- 12.13.1 BBI Life Sciences Company Information
- 12.13.2 BBI Life Sciences Business Overview
- 12.13.3 BBI Life Sciences Revenue in Large-Scale Oligonucleotide Synthesis Services Business (2021-2026)
- 12.13.4 BBI Life Sciences Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 12.13.5 BBI Life Sciences Recent Developments
- 12.14 Azenta Life Sciences
- 12.14.1 Azenta Life Sciences Company Information
- 12.14.2 Azenta Life Sciences Business Overview
- 12.14.3 Azenta Life Sciences Revenue in Large-Scale Oligonucleotide Synthesis Services Business (2021-2026)
- 12.14.4 Azenta Life Sciences Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 12.14.5 Azenta Life Sciences Recent Developments
- 12.15 Aurigene Pharmaceutical Services
- 12.15.1 Aurigene Pharmaceutical Services Company Information
- 12.15.2 Aurigene Pharmaceutical Services Business Overview
- 12.15.3 Aurigene Pharmaceutical Services Revenue in Large-Scale Oligonucleotide Synthesis Services Business (2021-2026)
- 12.15.4 Aurigene Pharmaceutical Services Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 12.15.5 Aurigene Pharmaceutical Services Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst